Eli Lilly Pays Record Fine for Off-Label Drug Marketing
Philadelphia, Pennsylvania— Multiple news publications have confirmed that Eli Lilly & Co. will, in the largest United States-imposed criminal fine on an individual company, pay…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Eli Lilly and Company
Eli Lilly and Company in More Hot Water
Montana is the latest state to sue Eli Lilly and Company, alleging that the company improperly and fraudulently marketed Zyprexa, an antipsychotic drug for unapproved…
Read More »Pharma Group Says “No” To Expensive Gifts to Doctors Which Could Influence Their Drug Choices
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a worldwide trade group said that under their revised ethics code that as of January 1,…
Read More »$30 Million Off-Label Case
The State of Mississipi has filed a sweeping lawsuit against the pharmaceutical company Eli Lilly (see www.lilly.com) alleging the pharmaceutical compay illegally marketed Zyprexa (an…
Read More »Are Clinical Drug Studies Being Manipulated?
A pharmaceutical company can violate the false claims act by submitting false statements in connection with drug applications and other records to the United States…
Read More »